| Name | Title | Contact Details |
|---|---|---|
Todd Garland |
Chief Commercial Officer | Profile |
Philippe Busque |
Senior Vice President of Global Sales and Services | Profile |
Dave Kennedy |
VP of Global Sales and Service | Profile |
Allen Poirson |
Senior Vice President of Marketing and Corporate Development | Profile |
Wenbin Jiang |
Chief Executive Officer | Profile |
Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn`s disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention.
parteqinnovations is a Kingston, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Apeel Sciences creates products from natural plant extracts that allow growers to reduce reliance on pesticides, increase produce quality, and provide superior shelf life without refrigeration.
Encore Rehabilitation is a Berkley, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Xenotech is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.